Ex vivo quantification of anti-tumor T-cell activity upon anti-PD-1 treatment in patient-derived lung tumor-on-chip
i. veith, a. mencattini, m. nurmik, i. damei, c. lansche, s. brosseau, g. gropplero, s. corgnac, j. filippi, n. pote, p. mordant, j. tosello, c. sedlik, e. piaggio, n. girard, , M. C. PARRINI
This study develops and validates lung-tumor-on-chip platforms to measure ex vivo anti-PD-1 treatment effects on T-cell activity using live imaging and image analysis.
bioRxiv · Jun 21, 2023 · PreprintCancer Biology